Sunshine Act has very low thresholds for reporting pharma-doc ties

05/28/2013 | OncLive

The thresholds have been set quite low for reporting financial relationships between doctors and drugmakers under the Sunshine Act, Dr. Andrew L. Pecora writes. A line-item breakdown must be provided of any transfer of value exceeding $10 at a time, or $100 for a year. "Think about it: a glass of wine is not a problem; add a crab cake, however, and your name is listed on a national database. The real question is, why were the thresholds for reporting set so low?" Pecora writes.

View Full Article in:

OncLive

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ